证券代码：002868 证券简称：*ST 绿康 公告编号：2025-092 绿康生化股份有限公司 关于控股股东部分股票质押展期的公告 公司控股股东及本公司董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 公司于近日收到控股股东上海康怡的通知，获悉其所持有的本公司部分股票办理了 质押展期，具体事项如下： 一、股东股份质押的基本情况 1. 本次股东股份质押展期基本情况 | 是否为 | 是 | 是 | 控股股 | 否 | | | | | | | | | | | | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 股 | 否 | 展期 | 质 | 东或第 | 本期质押 | 占其所 | 占公司 | 为 | 质押 | 质押 | 东 | 为 | 后质 | 质权 | 押 | | | | | | | | | | ...

Market Overview - The animal health sector increased by 1.25% on September 5, with Yongshun Biological leading the gains [1] - The Shanghai Composite Index closed at 3812.51, up 1.24%, while the Shenzhen Component Index closed at 12590.56, up 3.89% [1] Stock Performance - Yongshun Biological (839729) closed at 10.82, up 4.14% with a trading volume of 44,500 shares and a turnover of 47.80 million yuan [1] - Shilian Biological (688098) closed at 11.76, up 3.16% with a trading volume of 114,100 shares and a turnover of 132 million yuan [1] - Other notable performers include: - Houfeng Holdings (002141): closed at 3.96, up 2.33% [1] - KQ Biological (688526): closed at 18.00, up 2.16% [1] - Dayu Biological (871970): closed at 10.25, up 2.09% [1] Capital Flow - The animal health sector experienced a net outflow of 37.19 million yuan from institutional investors, while retail investors saw a net inflow of 13.24 million yuan [2] - Notable capital flows include: - Shilian Biological: net inflow of 500.11 thousand yuan from institutional investors [3] - Houfeng Holdings: net inflow of 91.15 thousand yuan from retail investors [3] - KQ Biological: net outflow of 297.54 thousand yuan from institutional investors [3]

Market Overview - The animal health sector experienced a decline of 0.2% on September 4, with Shunlian Biological leading the drop [1] - The Shanghai Composite Index closed at 3765.88, down 1.25%, while the Shenzhen Component Index closed at 12118.7, down 2.83% [1] Stock Performance - Notable gainers in the animal health sector included: - Qudongli (code: 838275) with a closing price of 11.96, up 6.50% [1] - Dayu Biological (code: 871970) with a closing price of 10.04, up 3.40% [1] - Yongshun Biological (code: 839729) with a closing price of 10.39, up 2.26% [1] - Conversely, Shunlian Biological (code: 688098) saw a decline of 2.98%, closing at 11.40 [2] Trading Volume and Capital Flow - The total trading volume for the animal health sector showed a net outflow of 85.41 million yuan from institutional investors, while retail investors saw a net inflow of 74.17 million yuan [2] - The capital flow for individual stocks indicated significant movements, with Shunlian Biological experiencing a net outflow of 10.12 million yuan from institutional investors [3] Individual Stock Analysis - Shunlian Biological had a total trading volume of 131,200 shares, with a net inflow of 7.73 million yuan from retail investors [3] - Other stocks like Huisheng Biological (code: 300871) and ST Green Kang (code: 002868) also showed varied capital flows, with Huisheng experiencing a net outflow of 12.50 million yuan from speculative funds [3]

Core Viewpoint - The announcement details that a significant shareholder of Green康生化股份有限公司 has had part of their shares frozen, but this will not affect the company's control or daily operations [1][2]. Group 1: Shareholder Information - The shareholder involved is Mr. Dong Hai and Xiamen International Trust Co., Ltd., who collectively had 1,500,000 shares frozen, representing 19.30% of their holdings and 0.97% of the company's total share capital [1][2]. - The total share capital of the company is noted to be 5%, and the frozen shares do not belong to the largest shareholder or actual controller [1][2]. Group 2: Impact on Company Operations - The freezing of shares will not lead to a change in the actual controller of the company and will not impact the company's daily operations or management [2][3]. - The company maintains independence in assets, business, and financial aspects from the involved shareholders, ensuring that governance and daily operations remain unaffected [3].

证券代码：002868 证券简称：*ST 绿康 公告编号：2025-091 绿康生化股份有限公司 关于持股 5%以上股东部分股份被冻结的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 1、截至本公告披露日，董海先生持有公司非限售流通股票 7,770,792 股，占 公司总股本比例为 5%，非公司第一大股东、控股股东或实际控制人及其一致行 动人，未在公司及下属子公司担任董事、监事、高级管理人员等职务。本次被司 法冻结股份 1,500,000 股，占其所持公司股份比例为 19.30%，占公司总股本比例 为 0.97%。其累计被冻结股份 1,500,000 股，占其所持公司股份比例为 19.30%， 占公司总股本比例为 0.97%。 2、截至本公告披露日，厦门国际信托持有公司非限售流通股票 7,770,792 股， 占公司总股本比例为 5%，非公司第一大股东、控股股东或实际控制人及其一致 行动人。本次被司法冻结股份 1,500,000 股，占其所持公司股份比例为 19.30%， 占公司总股本比例为 0.97%。其累计被冻结股份 1,500,000 股，占其所持 ...

Market Overview - The animal health sector experienced a decline of 2.2% on September 3, with the leading stock, Driveline, falling by 8.33% [1] - The Shanghai Composite Index closed at 3813.56, down 1.16%, while the Shenzhen Component Index closed at 12472.0, down 0.65% [1] Stock Performance - Key stocks in the animal health sector showed significant declines, with Driveline (code: 838275) closing at 11.23, down 8.33% on a trading volume of 49,500 shares and a transaction value of 57.66 million yuan [1] - Other notable declines included: - Yongshun Biological (code: 839729) down 4.78% to 10.16 [1] - Jinhai Biological (code: 002688) down 4.03% to 6.91 [1] - ST Lvkang (code: 002868) down 3.30% to 26.35 [1] - Houbang Holdings (code: 002141) down 3.24% to 3.88 [1] Capital Flow - The animal health sector saw a net outflow of 108 million yuan from major funds, while retail investors contributed a net inflow of 101 million yuan [1] - Detailed capital flow for specific stocks indicated: - Shunlian Biological (code: 688098) had a net inflow of 8.21 million yuan from major funds [2] - ST Lvkang (code: 002868) experienced a net outflow of 2.26 million yuan from major funds [2] - Houbang Holdings (code: 002141) faced a significant net outflow of 24.59 million yuan from major funds [2]

邮箱：lkshdm@pclifecome.com 地址：福建省浦城县园区大道 6 号 特此公告。 根据《深圳证券交易所股票上市规则》等有关规定，在公司董事会秘书空缺 期间，暂由公司董事长、总经理赖潭平先生代行董事会秘书职责。公司将按照相 关规定尽快完成董事会秘书的聘任工作。 赖潭平先生的联系方式如下： 电话：0599-2827451 传真：0599-2827567 证券代码：002868 证券简称：*ST 绿康 公告编号：2025-090 绿康生化股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 绿康生化股份有限公司（以下简称"公司"或"绿康生化"）董事会于近日 收到董事会秘书林信红女士的书面辞职报告，林信红女士因个人原因，申请辞去 公司董事会秘书职务。根据《公司法》《公司章程》等有关规定，其辞职报告自 送达董事会之日起生效。林信红女士辞职后，不再担任公司及子公司任何职务， 其辞职不会影响公司的正常经营。截至本公告日，林信红女士未持有公司股份。 林信红女士在公司任职期间恪尽职守、勤勉尽职，公司及董事会对林信红女士在 担任公司董事会秘书期间为公司发展 ...

*ST绿康表示，根据《深圳证券交易所股票上市规则》等有关规定，在公司董事会秘书空缺期间，暂由 公司董事长、总经理赖潭平代行董事会秘书职责。公司将按照相关规定尽快完成董事会秘书的聘任工 作。 交易行情显示，9月1日，*ST绿康涨停收盘，收于涨停价27.64元/股，总市值42.96亿元。 北京商报讯（记者 马换换 王蔓蕾）9月1日晚间，*ST绿康（002868）披露公告称，公司董事会于近日 收到董事会秘书林信红的书面辞职报告，林信红因个人原因，申请辞去公司董事会秘书职务。 公告显示，根据《公司法》《公司章程》等有关规定，其辞职报告自送达董事会之日起生效。林信红辞 职后，不再担任*ST绿康及子公司任何职务，其辞职不会影响公司的正常经营。截至公告日，林信红未 持有公司股份。 ...

证券代码：002868 证券简称：*ST 绿康 公告编号：2025-090 赖潭平先生的联系方式如下： 电话：0599-2827451 传真：0599-2827567 绿康生化股份有限公司 关于董事会秘书辞职的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 绿康生化股份有限公司（以下简称"公司"或"绿康生化"）董事会于近日 收到董事会秘书林信红女士的书面辞职报告，林信红女士因个人原因，申请辞去 公司董事会秘书职务。根据《公司法》《公司章程》等有关规定，其辞职报告自 送达董事会之日起生效。林信红女士辞职后，不再担任公司及子公司任何职务， 其辞职不会影响公司的正常经营。截至本公告日，林信红女士未持有公司股份。 林信红女士在公司任职期间恪尽职守、勤勉尽职，公司及董事会对林信红女士在 担任公司董事会秘书期间为公司发展做出的贡献表示衷心感谢！ 根据《深圳证券交易所股票上市规则》等有关规定，在公司董事会秘书空缺 期间，暂由公司董事长、总经理赖潭平先生代行董事会秘书职责。公司将按照相 关规定尽快完成董事会秘书的聘任工作。 2025 年 9 月 1 日 1 邮箱：lks ...

Market Overview - The animal health sector increased by 1.34% on September 1, with Jinhe Biology leading the gains [1] - The Shanghai Composite Index closed at 3875.53, up 0.46%, while the Shenzhen Component Index closed at 12828.95, up 1.05% [1] Stock Performance - Jinhe Biology (002688) closed at 7.53, up 6.06% with a trading volume of 875,700 shares and a turnover of 651 million yuan [1] - Other notable performers included *ST Lvkang (002868) with a 5.02% increase, and Shunlian Biology (688098) with a 1.78% increase [1] - The overall trading data for the animal health sector is summarized in the provided table [1] Capital Flow - The animal health sector saw a net inflow of 26.58 million yuan from institutional investors, while retail investors experienced a net outflow of 7.06 million yuan [2] - The detailed capital flow for individual stocks indicates varying levels of institutional and retail participation [3] Individual Stock Analysis - Jinhe Biology had a net inflow of 88.59 million yuan from institutional investors, while retail investors showed a net outflow of 37.91 million yuan [3] - Other stocks like Kexin Biology (688526) and *ST Lvkang (002868) also experienced mixed capital flows, with significant retail outflows [3]